Ashhar Bhurgri, MD
Psychiatry · Bakersfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 11 years
- University of Texas Medical School at San Antonio, 2015
Offices
3 locations · Kern Psychiatric Health and Wellness Center Inc · Transforming Minds Mental Health Services PC
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhurgri’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A159297 · Current
Licensed to practise in California · since 2018 · expires 2026-11-30 · Saba University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Original Medicare doctor bills
$82,033
Medicare paid this office $82,033 for 226 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 219 | $68,352 | $70 |
| Psychiatric diagnostic evaluation with medical services | 31 | $3,814 | $123 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $672 | $48 |
Who their Medicare patients are
226 Original Medicare patients in 2024. Average age 64 · Under 65 37% · Women 66% · Also on Medicaid 46% · Health risk score 1.41. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 74% · High blood pressure 67% · Diabetes 34% · Coronary heart disease 27% · COPD 25% · Chronic kidney disease 20% · Atrial fibrillation 13% · Heart failure 12% · Dementia 12% · Cancer 8% · Stroke 7%.
The office billed $633,838, Medicare allowed $112,954 and paid $82,033; for 1,118 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 226 | 1,118 | 64 | 1.41 | $633,838 | $82,033 |
| 2023 | 275 | 1,202 | 64 | 1.40 | $685,177 | $83,787 |
| 2022 | 329 | 1,496 | 64 | 1.45 | $845,570 | $113,893 |
| 2021 | 275 | 1,129 | 62 | 1.41 | $589,033 | $83,107 |
| 2020 | 267 | 927 | 59 | 1.54 | $370,676 | $58,685 |
| 2019 | 36 | 56 | 61 | 1.37 | $19,755 | $5,302 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 250 | $71,242 | $69 |
| Psychiatric diagnostic evaluation with medical services | 44 | $5,208 | $118 |
| Short return visit (20+ min) | 17 | $750 | $42 |
2022: 7 services
| Return visit (30+ min) | 269 | $75,824 | $71 |
| Psychiatric diagnostic evaluation with medical services | 108 | $12,417 | $114 |
| New patient visit (60+ min) | 34 | $4,896 | $144 |
| Psychotherapy with evaluation and management visit, 30 minutes | 51 | $3,452 | $51 |
| Return visit (30+ min) | 16 | $2,924 | $81 |
| Short return visit (20+ min) | 34 | $2,218 | $53 |
| Short return visit (20+ min) | 11 | $663 | $55 |
2021: 3 services
| Return visit (30+ min) | 229 | $62,570 | $78 |
| Psychiatric diagnostic evaluation with medical services | 124 | $14,714 | $117 |
| Short return visit (20+ min) | 106 | $4,328 | $32 |
2020: 7 services
| Psychiatric diagnostic evaluation with medical services | 160 | $17,154 | $106 |
| Return visit (30+ min) | 126 | $13,560 | $62 |
| Short return visit (20+ min) | 135 | $13,198 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $7,216 | $56 |
| Psychotherapy with evaluation and management visit, 30 minutes | 53 | $2,986 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,702 | $142 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,283 | $58 |
2019: 3 services
| Psychiatric diagnostic evaluation with medical services | 25 | $3,014 | $121 |
| Return visit (30+ min) | 11 | $1,320 | $88 |
| Short return visit (20+ min) | 11 | $855 | $61 |
Medicaid work
$24,502 in 2024
Medicaid paid $24,502 for 451 billed services this clinician did in 2024, up to 52 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 451 | $24,502 |
| 2024 | 451 | 1 | 52 | $24,502 |
| 2023 | 413 | 1 | 46 | $17,380 |
| 2022 | 179 | 1 | 21 | $10,336 |
| 2021 | 78 | 1 | 23 | $3,454 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 413 | $17,380 |
2022
| Return visit (30+ min) | 179 | $10,336 |
2021
| Return visit (30+ min) | 78 | $3,454 |
Drugs they prescribed that Part D paid
$821,339
Pharmacies billed $821,339 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,206) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
2,870 generic and 336 brand-name prescriptions · $821,339 in drug cost · 206 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Austedo | 19 | $171,331 | $9,017 |
| Rexulti | 103 | $167,515 | $1,626 |
| Invega Sustenna | 45 | $137,893 | $3,064 |
| Auvelity | 42 | $54,833 | $1,306 |
| Abilify Maintena | 18 | $47,862 | $2,659 |
See all 49 drugs
| Austedo | 19 | $171,331 | $9,017 |
| Rexulti | 103 | $167,515 | $1,626 |
| Invega Sustenna | 45 | $137,893 | $3,064 |
| Auvelity | 42 | $54,833 | $1,306 |
| Abilify Maintena | 18 | $47,862 | $2,659 |
| Trintellix | 22 | $14,488 | $659 |
| Belsomra | 18 | $8,735 | $485 |
| Aripiprazole | 101 | $5,455 | $54 |
| Lurasidone | 48 | $5,308 | $111 |
| Vyvanse | 14 | $5,221 | $373 |
| Eszopiclone | 130 | $2,720 | $21 |
| Sertraline | 292 | $2,422 | $8 |
| Quetiapine | 81 | $2,354 | $29 |
| Olanzapine | 58 | $2,185 | $38 |
| Trazodone | 250 | $2,004 | $8 |
| Mirtazapine | 190 | $1,825 | $10 |
| Bupropion Xl | 65 | $1,508 | $23 |
| Clozapine | 26 | $1,383 | $53 |
| Divalproex Sodium Er | 34 | $1,217 | $36 |
| Buspirone | 137 | $1,188 | $9 |
| Quetiapine Fumarate Er | 38 | $1,177 | $31 |
| Oxcarbazepine | 35 | $1,117 | $32 |
| Desvenlafaxine Succinate Er | 34 | $1,029 | $30 |
| Hydroxyzine | 96 | $924 | $10 |
| Duloxetine | 54 | $805 | $15 |
| Benztropine Mesylate | 77 | $774 | $10 |
| Dextroamphetamine-Amphet Er | 21 | $769 | $37 |
| Dextroamphetamine-Amphetamine | 25 | $717 | $29 |
| Fluoxetine | 71 | $711 | $10 |
| Naltrexone | 15 | $674 | $45 |
| Escitalopram | 126 | $657 | $5 |
| Alprazolam | 130 | $644 | $5 |
| Lamotrigine | 82 | $612 | $7 |
| Zaleplon | 19 | $533 | $28 |
| Gabapentin | 39 | $519 | $13 |
| Clonazepam | 150 | $453 | $3 |
| Prazosin | 25 | $452 | $18 |
| Temazepam | 16 | $430 | $27 |
| Risperidone | 41 | $391 | $10 |
| Ziprasidone | 26 | $368 | $14 |
| Venlafaxine Hcl Er | 16 | $278 | $17 |
| Bupropion Hcl Sr | 17 | $270 | $16 |
| Methylphenidate | 17 | $227 | $13 |
| Lorazepam | 67 | $165 | $2 |
| Lithium Carbonate | 21 | $164 | $8 |
| Zolpidem | 44 | $151 | $3 |
| Propranolol | 20 | $117 | $6 |
| Topiramate | 16 | $71 | $4 |
| Citalopram Hbr | 16 | $23 | $1 |
Year by year
| 2024 | 3,206 | 245 | 0% (0) | 10% | $821,339 |
| 2023 | 4,865 | 440 | 0% (0) | 8% | $1,113,381 |
| 2022 | 6,616 | 593 | 0% (0) | 7% | $966,162 |
| 2021 | 6,496 | 486 | 0% (0) | None | $709,433 |
| 2020 | 5,703 | 372 | 0% (0) | None | $513,867 |
| 2019 | 386 | 101 | 0% (0) | None | $21,957 |
| 2018 | 12 | None | 0% (0) | 0% | $315 |
| 2017 | 21 | None | 0% (0) | 0% | $881 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 54 drugs
| Austedo | 22 | $231,998 | $10,545 |
| Ingrezza | 18 | $145,805 | $8,100 |
| Rexulti | 74 | $126,871 | $1,714 |
| Invega Sustenna | 42 | $119,344 | $2,842 |
| Auvelity | 59 | $74,806 | $1,268 |
| Abilify Maintena | 26 | $72,333 | $2,782 |
| Latuda | 18 | $55,092 | $3,061 |
| Lurasidone | 40 | $35,212 | $880 |
| Aripiprazole | 221 | $25,431 | $115 |
| Vraylar | 14 | $20,509 | $1,465 |
| Trintellix | 21 | $16,676 | $794 |
| Belsomra | 33 | $15,543 | $471 |
| Sertraline | 510 | $6,813 | $13 |
| Trazodone | 480 | $6,803 | $14 |
| Desvenlafaxine Succinate Er | 60 | $4,960 | $83 |
| Olanzapine | 68 | $4,921 | $72 |
| Mirtazapine | 297 | $4,226 | $14 |
| Quetiapine | 151 | $3,769 | $25 |
| Bupropion Xl | 143 | $3,670 | $26 |
| Divalproex Sodium Er | 43 | $3,276 | $76 |
| Eszopiclone | 102 | $3,153 | $31 |
| Donepezil | 14 | $2,693 | $192 |
| Quetiapine Fumarate Er | 36 | $2,535 | $70 |
| Lamotrigine | 157 | $2,527 | $16 |
| Buspirone | 204 | $2,421 | $12 |
| Hydroxyzine | 151 | $2,420 | $16 |
| Clozapine | 37 | $2,202 | $60 |
| Escitalopram | 182 | $2,164 | $12 |
| Divalproex | 39 | $2,130 | $55 |
| Fluoxetine | 122 | $1,848 | $15 |
| Benztropine Mesylate | 128 | $1,683 | $13 |
| Alprazolam | 236 | $1,574 | $7 |
| Ramelteon | 11 | $1,499 | $136 |
| Dextroamphetamine-Amphetamine | 32 | $1,482 | $46 |
| Risperidone | 91 | $1,405 | $15 |
| Duloxetine | 53 | $1,288 | $24 |
| Dextroamphetamine-Amphet Er | 23 | $1,121 | $49 |
| Ziprasidone | 25 | $1,051 | $42 |
| Carbamazepine | 12 | $1,016 | $85 |
| Venlafaxine Hcl Er | 30 | $1,013 | $34 |
| Oxcarbazepine | 27 | $973 | $36 |
| Clonazepam | 217 | $954 | $4 |
| Naltrexone | 11 | $731 | $66 |
| Lorazepam | 96 | $686 | $7 |
| Methylphenidate | 30 | $682 | $23 |
| Gabapentin | 34 | $639 | $19 |
| Zolpidem | 53 | $496 | $9 |
| Prazosin | 33 | $462 | $14 |
| Bupropion Hcl Sr | 29 | $408 | $14 |
| Lithium Carbonate | 31 | $326 | $11 |
| Paroxetine | 25 | $269 | $11 |
| Temazepam | 17 | $225 | $13 |
| Citalopram Hbr | 27 | $137 | $5 |
| Propranolol | 11 | $102 | $9 |
2022: 56 drugs
| Latuda | 123 | $190,966 | $1,553 |
| Austedo | 20 | $156,653 | $7,833 |
| Invega Sustenna | 44 | $123,914 | $2,816 |
| Rexulti | 57 | $86,727 | $1,522 |
| Abilify Maintena | 21 | $56,399 | $2,686 |
| Aristada | 19 | $54,622 | $2,875 |
| Aripiprazole | 350 | $44,907 | $128 |
| Vraylar | 21 | $28,751 | $1,369 |
| Trintellix | 21 | $10,849 | $517 |
| Belsomra | 25 | $10,727 | $429 |
| Sertraline | 821 | $7,911 | $10 |
| Quetiapine | 273 | $7,580 | $28 |
| Trazodone | 673 | $7,580 | $11 |
| Desvenlafaxine Succinate Er | 29 | $5,758 | $199 |
| Mirtazapine | 332 | $5,666 | $17 |
| Duloxetine | 100 | $4,883 | $49 |
| Buspirone | 293 | $4,344 | $15 |
| Bupropion Xl | 158 | $4,317 | $27 |
| Quetiapine Fumarate Er | 48 | $4,121 | $86 |
| Escitalopram | 266 | $3,834 | $14 |
| Divalproex Sodium Er | 80 | $3,564 | $45 |
| Atomoxetine | 11 | $3,527 | $321 |
| Clozapine | 39 | $3,202 | $82 |
| Hydroxyzine | 211 | $2,829 | $13 |
| Oxcarbazepine | 62 | $2,762 | $45 |
| Eszopiclone | 63 | $2,694 | $43 |
| Naltrexone | 39 | $2,530 | $65 |
| Benztropine Mesylate | 183 | $2,280 | $12 |
| Fluoxetine | 224 | $2,100 | $9 |
| Gabapentin | 61 | $2,029 | $33 |
| Alprazolam | 355 | $1,964 | $6 |
| Olanzapine | 107 | $1,811 | $17 |
| Prazosin | 50 | $1,552 | $31 |
| Ziprasidone | 29 | $1,533 | $53 |
| Lamotrigine | 152 | $1,496 | $10 |
| Divalproex | 39 | $1,455 | $37 |
| Venlafaxine Hcl Er | 50 | $1,366 | $27 |
| Dextroamphetamine-Amphetamine | 27 | $1,283 | $48 |
| Risperidone | 123 | $1,261 | $10 |
| Clonazepam | 268 | $1,207 | $5 |
| Dextroamphetamine-Amphet Er | 29 | $1,024 | $35 |
| Carbamazepine | 18 | $995 | $55 |
| Bupropion Hcl Sr | 45 | $851 | $19 |
| Temazepam | 38 | $844 | $22 |
| Methylphenidate | 23 | $649 | $28 |
| Donepezil | 15 | $591 | $39 |
| Haloperidol | 14 | $550 | $39 |
| Fluvoxamine Maleate | 14 | $530 | $38 |
| Lorazepam | 110 | $525 | $5 |
| Zolpidem | 91 | $497 | $5 |
| Lithium Carbonate | 28 | $305 | $11 |
| Propranolol | 16 | $218 | $14 |
| Topiramate | 22 | $201 | $9 |
| Citalopram Hbr | 46 | $200 | $4 |
| Paroxetine | 11 | $191 | $17 |
| Hydroxyzine Pamoate | 18 | $158 | $9 |
2021: 57 drugs
| Latuda | 124 | $216,505 | $1,746 |
| Austedo | 19 | $95,473 | $5,025 |
| Rexulti | 52 | $67,596 | $1,300 |
| Aristada | 20 | $57,545 | $2,877 |
| Invega Sustenna | 30 | $55,229 | $1,841 |
| Vraylar | 25 | $32,686 | $1,307 |
| Aripiprazole | 289 | $18,083 | $63 |
| Trintellix | 25 | $9,932 | $397 |
| Quetiapine | 347 | $7,544 | $22 |
| Chlorpromazine | 14 | $7,047 | $503 |
| Trazodone | 617 | $6,181 | $10 |
| Divalproex Sodium Er | 91 | $6,090 | $67 |
| Sertraline | 712 | $5,594 | $8 |
| Desvenlafaxine Succinate Er | 45 | $5,392 | $120 |
| Oxcarbazepine | 101 | $4,410 | $44 |
| Mirtazapine | 294 | $4,154 | $14 |
| Escitalopram | 306 | $4,057 | $13 |
| Bupropion Xl | 175 | $3,300 | $19 |
| Buspirone | 241 | $3,295 | $14 |
| Duloxetine | 116 | $3,088 | $27 |
| Olanzapine | 160 | $3,000 | $19 |
| Alprazolam | 317 | $2,988 | $9 |
| Ziprasidone | 42 | $2,596 | $62 |
| Buprenorphine-Naloxone | 12 | $2,591 | $216 |
| Clozapine | 26 | $2,325 | $89 |
| Benztropine Mesylate | 193 | $2,256 | $12 |
| Doxepin | 11 | $2,152 | $196 |
| Venlafaxine Hcl Er | 82 | $2,052 | $25 |
| Haloperidol | 47 | $2,033 | $43 |
| Clonazepam | 305 | $1,941 | $6 |
| Naltrexone | 25 | $1,660 | $66 |
| Fluvoxamine Maleate | 21 | $1,619 | $77 |
| Quetiapine Fumarate Er | 16 | $1,502 | $94 |
| Divalproex | 41 | $1,413 | $34 |
| Lamotrigine | 134 | $1,332 | $10 |
| Dextroamphetamine-Amphet Er | 19 | $1,326 | $70 |
| Hydroxyzine | 130 | $1,321 | $10 |
| Gabapentin | 96 | $1,217 | $13 |
| Risperidone | 129 | $1,187 | $9 |
| Fluoxetine | 145 | $1,175 | $8 |
| Prazosin | 55 | $1,155 | $21 |
| Dextroamphetamine-Amphetamine | 32 | $1,082 | $34 |
| Bupropion Hcl Sr | 58 | $847 | $15 |
| Lorazepam | 147 | $772 | $5 |
| Eszopiclone | 20 | $711 | $36 |
| Methylphenidate | 42 | $684 | $16 |
| Zolpidem | 135 | $571 | $4 |
| Lithium Carbonate | 55 | $410 | $7 |
| Temazepam | 26 | $366 | $14 |
| Amitriptyline | 11 | $313 | $28 |
| Topiramate | 30 | $270 | $9 |
| Paroxetine | 33 | $248 | $8 |
| Clonidine | 21 | $206 | $10 |
| Citalopram Hbr | 48 | $194 | $4 |
| Propranolol | 14 | $146 | $10 |
| Hydroxyzine Pamoate | 15 | $138 | $9 |
| Nortriptyline | 13 | $75 | $6 |
2020: 54 drugs
| Latuda | 100 | $153,504 | $1,535 |
| Aristada | 21 | $58,354 | $2,779 |
| Rexulti | 41 | $52,682 | $1,285 |
| Invega Sustenna | 22 | $31,196 | $1,418 |
| Vraylar | 15 | $18,280 | $1,219 |
| Aripiprazole | 278 | $17,342 | $62 |
| Trintellix | 28 | $10,956 | $391 |
| Vyvanse | 12 | $8,046 | $670 |
| Quetiapine | 339 | $5,972 | $18 |
| Duloxetine | 168 | $4,858 | $29 |
| Trazodone | 500 | $4,449 | $9 |
| Sertraline | 520 | $3,664 | $7 |
| Bupropion Xl | 148 | $3,585 | $24 |
| Desvenlafaxine Succinate Er | 35 | $3,503 | $100 |
| Divalproex Sodium Er | 86 | $3,495 | $41 |
| Viibryd | 11 | $3,119 | $284 |
| Escitalopram | 269 | $3,083 | $11 |
| Oxcarbazepine | 77 | $2,865 | $37 |
| Mirtazapine | 163 | $2,804 | $17 |
| Ziprasidone | 52 | $2,722 | $52 |
| Alprazolam | 356 | $2,668 | $7 |
| Quetiapine Fumarate Er | 23 | $2,589 | $113 |
| Methylphenidate Er | 11 | $2,318 | $211 |
| Haloperidol | 49 | $2,185 | $45 |
| Benztropine Mesylate | 200 | $2,178 | $11 |
| Buspirone | 88 | $2,161 | $25 |
| Clonazepam | 319 | $2,120 | $7 |
| Olanzapine | 134 | $1,948 | $15 |
| Clozapine | 28 | $1,941 | $69 |
| Venlafaxine Hcl Er | 59 | $1,514 | $26 |
| Lorazepam | 169 | $1,471 | $9 |
| Fluoxetine | 137 | $1,426 | $10 |
| Risperidone | 158 | $1,260 | $8 |
| Prazosin | 60 | $985 | $16 |
| Divalproex | 44 | $961 | $22 |
| Dextroamphetamine-Amphet Er | 12 | $943 | $79 |
| Hydroxyzine | 76 | $938 | $12 |
| Lamotrigine | 113 | $928 | $8 |
| Temazepam | 48 | $861 | $18 |
| Gabapentin | 79 | $789 | $10 |
| Dextroamphetamine-Amphetamine | 17 | $781 | $46 |
| Zolpidem | 127 | $685 | $5 |
| Bupropion Hcl Sr | 50 | $619 | $12 |
| Topiramate | 52 | $449 | $9 |
| Carbamazepine | 17 | $426 | $25 |
| Methylphenidate | 22 | $401 | $18 |
| Paroxetine | 44 | $335 | $8 |
| Clorazepate Dipotassium | 14 | $333 | $24 |
| Naltrexone | 14 | $300 | $21 |
| Lithium Carbonate | 40 | $243 | $6 |
| Citalopram Hbr | 47 | $207 | $4 |
| Donepezil | 20 | $201 | $10 |
| Clonidine | 21 | $194 | $9 |
| Propranolol | 15 | $116 | $8 |
2019: 11 drugs
| Aripiprazole | 18 | $3,968 | $220 |
| Duloxetine | 24 | $1,471 | $61 |
| Quetiapine | 31 | $472 | $15 |
| Sertraline | 43 | $423 | $10 |
| Bupropion Xl | 17 | $352 | $21 |
| Trazodone | 26 | $306 | $12 |
| Alprazolam | 30 | $211 | $7 |
| Mirtazapine | 11 | $190 | $17 |
| Olanzapine | 13 | $144 | $11 |
| Escitalopram | 13 | $137 | $11 |
| Clonazepam | 24 | $113 | $5 |
Money from drug and device companies
$138 in 2025
| 2025 | 4 | 5 | None | $138 |
| 2024 | 6 | 10 | None | $195 |
| 2023 | 14 | 40 | None | $810 |
| 2022 | 15 | 90 | None | $1,568 |
| 2021 | 14 | 70 | None | $2,058 |
| 2020 | 10 | 80 | None | $1,157 |
| 2019 | 5 | 11 | None | $212 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $61 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $35 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $27 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $16 | 1 payment
|
See all 5 published payments
| Teva Pharmaceuticals USA | Meals · 2025-12-07 | Austedo Xr | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-07-18 | Abilify Asimtufii | $16 |
| Janssen Pharmaceuticals | Meals · 2025-04-30 | Invega Sustenna | $35 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-08 | Cobenfy | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-24 | Cobenfy | $35 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $195
| Teva Pharmaceuticals USA | Austedo Xr | $60 | 3 payments
|
| Lundbeck | Rexulti | $37 | 2 payments
|
| Alkermes | Aristada | $31 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $24 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $23 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $20 | 1 payment
|
2023: $810
| Supernus Pharmaceuticals | Qelbree | $165 | 12 payments
|
| Axsome Therapeutics | Auvelity | $136 | 3 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $115 | 6 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $99 | 5 payments
|
| AbbVie | Vraylar | $48 | 2 payments
|
| Lundbeck | Abilify Maintena | $44 | 2 payments
|
| Indivior | Sublocade | $41 | 2 payments
|
| Alkermes | Aristada | $40 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $24 | 1 payment
|
| Braeburn | Brixadi | $23 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $21 | 1 payment
|
| Iti | Caplyta | $20 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm | $18 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $18 | 1 payment
|
2022: $1,568
| Supernus Pharmaceuticals | Qelbree | $428 | 27 payments
|
| Sunovion Pharmaceuticals | Latuda | $326 | 17 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $134 | 9 payments
|
| Lundbeck | Rexulti | $118 | 8 payments
|
| Abbvie | Vraylar | $108 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo | $89 | 4 payments
|
| Iti | Caplyta | $67 | 4 payments
|
| Alkermes | Vivitrol | $61 | 3 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $56 | 3 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $49 | 2 payments
|
| Corium | Azstarys | $38 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $38 | 2 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $22 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $19 | 1 payment
|
| Almatica Pharma | Gralise | $18 | 1 payment
|
2021: $2,058
| Neuronetics | Neurostar Tms Therapy | $940 | 3 payments
|
| Supernus Pharmaceuticals | Qelbree | $208 | 10 payments
|
| Sunovion Pharmaceuticals | Latuda | $190 | 9 payments
|
| Lundbeck | Rexulti | $183 | 12 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $167 | 18 payments
|
| Iti | Caplyta | $74 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $67 | 3 payments
|
| AbbVie | Vraylar | $53 | 3 payments
|
| Alkermes | Aristada | $49 | 2 payments
|
| Indivior | Perseris | $39 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo | $31 | 2 payments
|
| Corium | Azstarys | $24 | 1 payment
|
| Eisai | Dayvigo | $17 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $15 | 1 payment
|
2020: $1,157
| Lundbeck | Rexulti | $310 | 25 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $200 | 12 payments
|
| Otsuka America Pharmaceutical | Rexulti | $180 | 10 payments
|
| Alkermes | Aristada | $135 | 9 payments
|
| Allergan | Vraylar | $133 | 15 payments
|
| Neurocrine Biosciences | Ingrezza | $75 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $58 | 2 payments
|
| Iti | Caplyta | $29 | 2 payments
|
| Merck Sharp & Dohme | Belsomra | $20 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $17 | 1 payment
|
2019: $212
| Alkermes | Aristada | $99 | 5 payments
|
| Indivior | Sublocade | $60 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $23 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $19 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1932580925
- Licence
- CA A159297California A159297: Current · expires 2026-11-30
- Trained
- University of Texas Medical School at San Antonio, 2015 · 11 years ago
- Group
- Kern Psychiatric Health and Wellness Center Inc · Transforming Minds Mental Health Services PC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- Po Box 10748, Bakersfield, CA, 93389
- NPI first listed
- 2015-06-15
- NPI last updated
- 2020-02-21
- NPI record certified
- 2020-02-21
This is when the NPI record was last certified, not a medical board exam.